Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Med/Surg Distributor Exchange Will Seek Link To Manufacturer-Led B2B Site

This article was originally published in The Gray Sheet

Executive Summary

The New Health Exchange e-commerce business being established by five wholesale distributors in the medical supply industry will actively seek to link to the supplier-led exchange being developed by several device manufacturers, while leaving open the possibility of linkages to pure-play "dot com" portals.

You may also be interested in...



Bergen Brunswig Exiting Med/Surg Business Via $181 Mil. Sale To Cardinal

Bergen Brunswig will leave the medical and surgical supplies business following the sale of its Bergen Brunswig Medical Corp. (BBMC) subsidiary to Cardinal Health's Allegiance unit for $181 mil. cash, under a definitive agreement announced June 26.

Bergen Brunswig Exiting Med/Surg Business Via $181 Mil. Sale To Cardinal

Bergen Brunswig will leave the medical and surgical supplies business following the sale of its Bergen Brunswig Medical Corp. (BBMC) subsidiary to Cardinal Health's Allegiance unit for $181 mil. cash, under a definitive agreement announced June 26.

MedAssets.com Focusing On Non-EDI Compliant Alternate Site Market

MedAssets.com's refurbished capital medical equipment exchange netted $3 mil. in sales over the Internet in March, according to CEO John Bardis.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013281

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel